SCHEMBL30656268

SCHEMBL30656268

CN1CCC(NC(=O)c2c(C(F)F)sc3ccc(OCc4ccccc4)cc23)CC1

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SLC6A5 Q9Y345 12/20 0.49
HTR3A P46098 2/20 0.47
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
EDNRA P25101 1/20 0.44
SSTR4 P31391 1/20 0.42
USP2 O75604 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
KMT2A Q03164 1/20 0.41
ESR2 Q92731 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30656061 0.95 SLC6A5 (0.47) SLC6A5HTR3AMAOAMAOBEDNRA
SCHEMBL26793496 0.88 SLC6A5 (0.49) SLC6A5HTR3AMAOAMAOBEDNRA
SCHEMBL30656217 0.85 EDNRA (0.46) HTR3AMAOAMAOBEDNRAMAPT
SCHEMBL26793660 0.84 HTR3A (0.44) HTR3AMAOAMAOBEDNRAMAPT
SCHEMBL30656300 0.83 EDNRA (0.41) HTR3AMAOAMAOBEDNRAUSP2
SCHEMBL30656320 0.82 SLC6A5 (0.49) SLC6A5HTR3AMAOAMAOBEDNRA
SCHEMBL30656275 0.82 EDNRA (0.52) MAOAMAOBEDNRAMAPTKMT2A
SCHEMBL31350343 0.82 HTR3A (0.47) SLC6A5HTR3ASSTR4KMT2A
SCHEMBL30656043 0.80 APOL1 (0.49) HTR3AMAOAMAOBEDNRAMAPT
SCHEMBL31351336 0.79 EDNRA (0.53) MAOAMAOBEDNRAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP claimed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO claimed
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP disclosed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed